HUTCHMED (China) (HUTCHMED (China)) EV-to-EBITDA

: 31.44 (As of Today)

View and export this data going back to 2016. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HUTCHMED (China)'s enterprise value is $2,115.3 Mil. HUTCHMED (China)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $67.3 Mil. Therefore, HUTCHMED (China)'s EV-to-EBITDA for today is 31.44.

The historical rank and industry rank for HUTCHMED (China)'s EV-to-EBITDA or its related term are showing as below:

HCM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -325.75 Med: -27.1 Max: 110.36
Current: 31.44

During the past 13 years, the highest EV-to-EBITDA of HUTCHMED (China) was 110.36. The lowest was -325.75. And the median was -27.10.

HCM's EV-to-EBITDA is ranked worse than
85.29% of 707 companies
in the Drug Manufacturers industry
Industry Median: 13.81 vs HCM: 31.44

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), HUTCHMED (China)'s stock price is $17.99. HUTCHMED (China)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.550. Therefore, HUTCHMED (China)'s PE Ratio for today is 32.71.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

HUTCHMED (China) EV-to-EBITDA Historical Data

The historical data trend for HUTCHMED (China)'s EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

-23.40

-22.59

-24.58

-5.34

33.75

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-24.58	-	-5.34	-	33.75

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HUTCHMED (China) EV-to-EBITDA Distribution

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s EV-to-EBITDA falls into.

HUTCHMED (China) EV-to-EBITDA Calculation

HUTCHMED (China)'s EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	2115.320	/	67.274
	=	31.44

HUTCHMED (China)'s current Enterprise Value is $2,115.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HUTCHMED (China)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $67.3 Mil.

HUTCHMED (China) (NAS:HCM) EV-to-EBITDA Explanation

HUTCHMED (China)'s PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	17.99	/	0.550
	=	32.71

HUTCHMED (China)'s share price for today is $17.99.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HUTCHMED (China)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.550.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

HUTCHMED (China) EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.